NUPR1-dependent metallothionein-2 transcription attenuates ferroptosis-associated myocardial injury in diabetic cardiomyopathy
This study demonstrates that the stress-responsive transcription factor NUPR1 protects against diabetic cardiomyopathy by transcriptionally activating metallothionein-2 (MT2) to suppress ferroptosis-associated iron accumulation and lipid peroxidation, thereby preserving cardiac function and structure.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The heart is a muscle that never rests, and like any hardworking engine, it requires a delicate balance of fuel and protection to keep running smoothly. In people with diabetes, this balance is often disrupted. High levels of sugar and fat in the blood create a toxic environment that damages heart cells, leading to a condition called diabetic cardiomyopathy. This disease causes the heart muscle to thicken, stiffen, and eventually fail, often without the blockages typical of a standard heart attack. A key part of this damage involves a specific type of cell death driven by rust-like chemical reactions. Just as iron rusts when exposed to oxygen and moisture, certain fats inside heart cells can undergo a similar process called lipid peroxidation when iron levels get out of control. This "rusting" destroys the cell from the inside, and scientists have long sought to understand what natural defenses the heart might have to stop it.
Researchers at Jinan University and other institutions in China have now uncovered a critical piece of this protective puzzle. They discovered that the heart naturally produces a stress-response protein called NUPR1 when it is under attack from diabetes. This protein acts as a master switch, turning on a second defense system known as metallothionein-2. This second protein functions like a sponge, soaking up excess iron and neutralizing the toxic chemical reactions that would otherwise destroy the heart cell. The study shows that when this NUPR1-metallothionein-2 pathway is working, the heart is better able to withstand the toxic environment of diabetes. However, when the researchers blocked this pathway, the heart cells suffered severe damage, filling with iron and dying at a much faster rate.
To understand how this works, the team first looked at mice that had been made diabetic through a high-fat diet and a specific chemical treatment. They found that the hearts of these diabetic mice naturally produced higher levels of NUPR1, suggesting the body was trying to fight back against the damage. To test if this was truly helpful, the scientists used a virus to lower the amount of NUPR1 in the hearts of diabetic mice. Without this protein, the mice developed much worse heart failure, their heart muscles became more disorganized, and they accumulated dangerous levels of iron and toxic fats. Conversely, when the scientists increased the amount of NUPR1 in the hearts of diabetic mice, the damage was significantly reduced. The hearts pumped more effectively, the muscle structure remained intact, and the toxic iron buildup was kept in check.
The researchers then traced exactly how NUPR1 provided this protection. They found that NUPR1 goes directly into the cell's control center and binds to the instructions for making metallothionein-2, effectively telling the cell to produce more of it. Metallothionein-2 is a small protein rich in sulfur that is excellent at binding to metals like zinc and iron. By increasing the levels of this protein, NUPR1 ensures that the heart has enough of this "iron sponge" to prevent the rust-like damage that kills cells. When the team silenced the metallothionein-2 gene in heart cells, the protective effect of NUPR1 disappeared, proving that the two work together in a direct chain of command.
Beyond just understanding the mechanism, the team explored whether this discovery could lead to a new way to treat the disease. They developed a method to deliver the genetic instructions for NUPR1 directly into the bloodstream using tiny, fat-based bubbles called lipid nanoparticles. These bubbles are designed to carry genetic messages safely through the body and release them into the heart. When they injected these nanoparticles into diabetic mice, the hearts began producing NUPR1 again, which in turn boosted metallothionein-2 levels. The result was a marked improvement in heart function and a reduction in tissue scarring. This suggests that giving the heart a temporary boost of this natural defense protein could be a viable strategy for treating diabetic heart disease.
The study also looked at whether simply adding zinc, a mineral that metallothionein-2 relies on, could help. While giving extra zinc to diabetic mice did not significantly improve heart function on its own, it did help mice that were specifically lacking NUPR1. This indicates that the benefit of zinc depends on the heart having the NUPR1 system in place to use it effectively. The researchers concluded that the NUPR1-metallothionein-2 pathway is a vital, built-in defense that the heart tries to use when under diabetic stress. While the work was done in mice and requires further testing to see if it applies to humans, it offers a clear new target for future therapies. By reinforcing this specific natural pathway, doctors might one day be able to prevent the silent, rust-like destruction of the heart muscle in people with diabetes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.